본문 바로가기
KERD
논문KCI 등재

Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea

이경원|신종희|용동은|정윤섭|하경임|박기형|정석훈|임환섭
연세대학교의과대학 (Yonsei University College of Medicine)|2006.02|Yonsei Medical Journal|제47권 제1호|pp. 43-54

2

조회

0

다운로드

14

인용

0

참고문헌

주제분류의학일반

초록

Abstract

Monitoring temporal trends of antimicrobial resistance can provide useful information for the empirical selection of antimicrobial agents to treat infected patients and for the control of nosocomial infections. In this study, we analyzed antimicrobial resistance of clinically relevant bacteria in 2003 at Korean hospitals and at a commercial laboratory. The following organism-antimicrobial agent resistance combinations were very prevalent: oxacillin-resistant Staphylococcus aureus (68%), expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae (25%), and fluoroquinolone-resistant Escherichia coli (33%), Acinetobacter spp. (58%), and Pseudomonas aeruginosa (40%). Moreover, gradual increases in vancomycin- resistant Enterococcus faecium (20%), cefoxitin-resistant E. coli (10%) and K. pneumoniae (23%), and imipenem-resistant P. aeruginosa (20%) and Acinetobacter spp. (13%) were also observed. The resistance rates of Acinetobacter spp. to most antimicrobial agents at hospitals and at the commercial laboratory were similar. Among the Acinetobacter spp. isolated at a tertiary-care hospital, 46.2% were multidrug-resistant to 9-12 of 13 antimicrobial agents, and 18.3% were panresistant. The exclusion of duplicate isolates at a tertiary-care hospital significantly lowered the proportion of oxacillin-resistant S. aureus, vancomycin-resistant E. faecium, and fluoroquinolone-resistant E. coli.

참고문헌 (37)

  1. "The relentless rise of resistance?", 54, pp.306~310 (2004)
  2. "Surveillance of antimicrobial resistance- what, how and whither?", 7, pp.316~325 (2001)
  3. "Antibiotic resistance surveillance: action for international studies", 49, pp.7~10 (2002)
  4. "The Alexander project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections", 45, pp.191~203 (2000)
  5. "Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae", 9, pp.1089~1095 (2003)
  6. "European recommendations for antimicrobial resistance surveillance", 10, pp.349~383 (2004)
  7. "Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997", 39, pp.569~577 (1998)
  8. "Increasing prevalence of vancomyin-resistant enterococci, and cefoxitin-, imipenem-and fluoroquinolone-resistant gram-negative bacilli; a KONSAR study in 2002", 45, pp.598~608 (2004)
  9. "VIM-and IMP-type metallo- -lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals", 9, pp.868~871 (2003)
  10. "Plasmid mediated ampC genes in cefoxitin- resistantE. coli and K. pneumoniae clinical isolates" (2004)
  11. "Considerations in control and treatmentof nosocomial infections due to multidrug-resistant Acinetobacter baumannii", 36, pp.1268~1274 (2003)
  12. "Analysis and presentation of cumulative antimicrobial susceptibility test data" (2002), NCCLS
  13. "Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project Hospitals", 8, pp.697~701 (2002)
  14. "Surveillance of antimicrobial resistance: the WHONET program", 24, pp.157~168 (1997)
  15. "Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database- USA", 29, pp.259~263 (1999)
  16. "Performance standards for antimicrobial susceptibility testing: thirteen's informational supplement" (2003), NCCLS
  17. "Identification of CTX-M-14 extended-spectrum -lactamasein clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea", 39, pp.3747~379 (2001)
  18. "Growing group of extended-spectrum - lactamases: the CTX-M enzymes", 48, pp.1~14 (2004)
  19. "Epidemiological study of methicillin-resistant Staphylococcus aureus atFukuoka University Hospital", 5, pp.207~213 (1999)
  20. "Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002", 10, pp.1627~1634 (2004)
  21. "Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens", 38, pp.1570~1578 (2004)
  22. "Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project", 51, pp.195~200 (2005)
  23. "Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002)", 43, pp.462~463 (2005)
  24. "The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000", 48, pp.211~219 (2004)
  25. "Rapidly increasing prevalence of -lactamase-nonproducing ampicillin- resistant Haemophilus influenzae type b in patients with meningitis", 48, pp.1509~1514 (2004)
  26. "Characteristics of epidemic multidrug-resistant Salmonella enterica serovar Typhimurium DT104 strains first isolated in Korea", 34, pp.1~8 (2002)
  27. "Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean Nationwide Survey", 42, pp.2902~2906 (2004)
  28. "Carbapenemases: a problem in waiting?", 3, pp.489~495 (2000)
  29. "Screening and identification of metallo- -lactamase gene in clinical isolates of imipenem-resistant Pseudomonas aeruginosa", 24, pp.177~182 (2004)
  30. "An epidemiological study of the susceptibility andfrequency of multiple-drug-resistant strains of Pseudomonas aeruginosa isolated at medical institutes nationwide in Japan", 11, pp.64~70 (2005)
  31. "Characterization of a new integron containing VIM-2 in a clinical isolate of Enterobacter cloacae", 51, pp.397~400 (2003)
  32. "The future of the quinolones", 19, pp.1~5 (2001)
  33. "Multidrug-resistant Acinetobacter baumannii", 11, pp.22~29 (2005)
  34. "Dissemination of a clone of unusual phenotype of pandrug- resistant Acinetobacter baumannii at a university hospital in Taiwan", 42, pp.1759~1763 (2004)
  35. "Polymyxin-resistant Acinetobacter spp. isolates; what is next?", 9, pp.1025~1027 (2003)
  36. "Optimal use of antibiotic resistance surveillance systems", 10, pp.502~511 (2004)
  37. "Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient", 42, pp.4776~4779 (2004)

관련 논문AI추천

Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009강정옥, 김미나, 김재석, 박연준, 신종희, 용동은, 이경원, 장숙진, 정석훈, 홍혜림, The KONSAR Group, Yunsop Chong연세대학교의과대학 · Yonsei Medical Journal2011 · 제52권 제5호Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007고은미, 김선주, 김진주, 노경호, 용동은, 이경원, 이미애, 이종욱, 이채훈, 정윤섭연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제6호Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015김도균, 안지영, 용동은, 이경원, 이채훈, 이혁민, 장숙진, 정석훈대한진단검사의학회 · Annals of Laboratory Medicine2017 · 제37권 제3호Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non- Typhoidal Salmonella Species김용근, 신희봉, 용동은, 이경원, 이위교, 정석훈, 정윤섭, 조지현, 최태열, 하경임대한감염학회 · Infection and Chemotherapy2014 · 제46권 제2호High Prevalence of Ceftazidime-Resistant Klebsiella pneumoniae and Increase of Imipenem-Resistant어영, 김희준, 용동은, 이경원, 이위규, 임장현, 정윤섭, 조지현연세대학교의과대학 · Yonsei Medical Journal2006 · 제47권 제5호Are Community-Based Hospitals Safe from Carbapenem-Resistant Enterobacteriaceae in Korea?이창섭대한감염학회 · Infection and Chemotherapy2016 · 제48권 제3호

이 간행물의 다른 논문 (12건)

Human Papillomavirus Type 16 E5 Protein as a Therapeutic Target김상우, 양주성pp. 1-14Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia김연아, 용동은, 이경원, 송영구, 최준용, 윤희정, 신소연, 김창오, 박윤선, 김준명, 김영근, 김명수pp. 63-69Radiologic and Clinical Features of Idiopathic Granulomatous Lobular Mastitis Mimicking Advanced Breast Cancer정우희, 김은경, 이한경, 이제희, 곽규성, 오기근pp. 78-84Quantitative EMG Changes During 12-Week DeLorme's Axiom Strength Training조상현, 이영희, 권오윤, 신화경pp. 93-104The Actual Five-year Survival Rate of Hepatocellular Carcinoma Patients after Curative Resection박준성, 최진섭, 윤동섭, 이우정, 김병로, 이재길, 강창무, 김경식pp. 105-112
원문 보기